Trial intelligence / Profile preview

Clonidine for Iatrogenic Opioid Dependence in Infants

NCT01360450Phase 3Terminated

Sponsor
Johns Hopkins University
Start
Jul 2011
Primary completion
Jul 2011
Countries
1
01

Overview

A Phase 3 trial of Clonidine Lauriad in neonatal abstinence syndrome (NAS), sponsored by Johns Hopkins University. Started Jul 2011; status: terminated.

02

Drugs

Clonidine Lauriad
03

Conditions

neonatal abstinence syndrome (NAS)

Beyond the preview

Go deeper on NCT01360450.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01360450.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call